CVS HEALTH CORP (1CVS.MI) Stock Fundamental Analysis

BIT:1CVS • US1266501006

66.41 EUR
+4.15 (+6.67%)
Last: Feb 12, 2026, 07:00 PM
Fundamental Rating

4

1CVS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 32 industry peers in the Health Care Providers & Services industry. 1CVS has a bad profitability rating. Also its financial health evaluation is rather negative. 1CVS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • 1CVS had positive earnings in the past year.
  • In the past year 1CVS had a positive cash flow from operations.
  • Each year in the past 5 years 1CVS has been profitable.
  • Each year in the past 5 years 1CVS had a positive operating cash flow.
1CVS.MI Yearly Net Income VS EBIT VS OCF VS FCF1CVS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

1.2 Ratios

  • 1CVS's Return On Assets of 0.18% is on the low side compared to the rest of the industry. 1CVS is outperformed by 72.41% of its industry peers.
  • Looking at the Return On Equity, with a value of 0.64%, 1CVS is doing worse than 75.86% of the companies in the same industry.
  • 1CVS has a Return On Invested Capital of 4.90%. This is comparable to the rest of the industry: 1CVS outperforms 44.83% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1CVS is in line with the industry average of 6.99%.
Industry RankSector Rank
ROA 0.18%
ROE 0.64%
ROIC 4.9%
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
1CVS.MI Yearly ROA, ROE, ROIC1CVS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

1.3 Margins

  • The Profit Margin of 1CVS (0.12%) is worse than 72.41% of its industry peers.
  • 1CVS's Profit Margin has declined in the last couple of years.
  • The Operating Margin of 1CVS (2.73%) is worse than 72.41% of its industry peers.
  • In the last couple of years the Operating Margin of 1CVS has declined.
  • With a Gross Margin value of 13.88%, 1CVS is not doing good in the industry: 62.07% of the companies in the same industry are doing better.
  • 1CVS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.73%
PM (TTM) 0.12%
GM 13.88%
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-4.91%
1CVS.MI Yearly Profit, Operating, Gross Margins1CVS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1CVS is destroying value.
  • Compared to 1 year ago, 1CVS has more shares outstanding
  • The number of shares outstanding for 1CVS has been reduced compared to 5 years ago.
  • The debt/assets ratio for 1CVS has been reduced compared to a year ago.
1CVS.MI Yearly Shares Outstanding1CVS.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
1CVS.MI Yearly Total Debt VS Total Assets1CVS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B 200B 250B

2.2 Solvency

  • 1CVS has an Altman-Z score of 2.26. This is not the best score and indicates that 1CVS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.26, 1CVS is doing good in the industry, outperforming 72.41% of the companies in the same industry.
  • 1CVS has a debt to FCF ratio of 10.46. This is a negative value and a sign of low solvency as 1CVS would need 10.46 years to pay back of all of its debts.
  • 1CVS has a Debt to FCF ratio (10.46) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.85 indicates that 1CVS is somewhat dependend on debt financing.
  • 1CVS's Debt to Equity ratio of 0.85 is in line compared to the rest of the industry. 1CVS outperforms 51.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 10.46
Altman-Z 2.26
ROIC/WACC0.64
WACC7.68%
1CVS.MI Yearly LT Debt VS Equity VS FCF1CVS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • A Current Ratio of 0.83 indicates that 1CVS may have some problems paying its short term obligations.
  • The Current ratio of 1CVS (0.83) is comparable to the rest of the industry.
  • A Quick Ratio of 0.63 indicates that 1CVS may have some problems paying its short term obligations.
  • 1CVS has a Quick ratio of 0.63. This is comparable to the rest of the industry: 1CVS outperforms 41.38% of its industry peers.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.63
1CVS.MI Yearly Current Assets VS Current Liabilites1CVS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

4

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 7.87% over the past year.
  • 1CVS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.20% yearly.
  • Looking at the last year, 1CVS shows a small growth in Revenue. The Revenue has grown by 6.82% in the last year.
  • Measured over the past years, 1CVS shows a small growth in Revenue. The Revenue has been growing by 7.74% on average per year.
EPS 1Y (TTM)7.87%
EPS 3Y-13.62%
EPS 5Y-5.2%
EPS Q2Q%46.79%
Revenue 1Y (TTM)6.82%
Revenue growth 3Y8.47%
Revenue growth 5Y7.74%
Sales Q2Q%7.8%

3.2 Future

  • 1CVS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.81% yearly.
  • The Revenue is expected to grow by 4.65% on average over the next years.
EPS Next Y24.02%
EPS Next 2Y15.59%
EPS Next 3Y15.31%
EPS Next 5Y13.81%
Revenue Next Year7.59%
Revenue Next 2Y5.06%
Revenue Next 3Y5.17%
Revenue Next 5Y4.65%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1CVS.MI Yearly Revenue VS Estimates1CVS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100B 200B 300B 400B 500B
1CVS.MI Yearly EPS VS Estimates1CVS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

  • 1CVS is valuated reasonably with a Price/Earnings ratio of 11.39.
  • Based on the Price/Earnings ratio, 1CVS is valued cheaply inside the industry as 86.21% of the companies are valued more expensively.
  • 1CVS is valuated cheaply when we compare the Price/Earnings ratio to 26.64, which is the current average of the S&P500 Index.
  • 1CVS is valuated reasonably with a Price/Forward Earnings ratio of 10.78.
  • 82.76% of the companies in the same industry are more expensive than 1CVS, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of 1CVS to the average of the S&P500 Index (27.75), we can say 1CVS is valued rather cheaply.
Industry RankSector Rank
PE 11.39
Fwd PE 10.78
1CVS.MI Price Earnings VS Forward Price Earnings1CVS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Price/Free Cash Flow ratio as 1CVS.
Industry RankSector Rank
P/FCF 15.74
EV/EBITDA N/A
1CVS.MI Per share data1CVS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

  • 1CVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 1CVS's earnings are expected to grow with 15.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.47
PEG (5Y)N/A
EPS Next 2Y15.59%
EPS Next 3Y15.31%

6

5. Dividend

5.1 Amount

  • 1CVS has a Yearly Dividend Yield of 3.44%.
  • Compared to an average industry Dividend Yield of 1.65, 1CVS pays a better dividend. On top of this 1CVS pays more dividend than 93.10% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, 1CVS pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.44%

5.2 History

  • The dividend of 1CVS has a limited annual growth rate of 5.96%.
Dividend Growth(5Y)5.96%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 1CVS pays out 722.81% of its income as dividend. This is not a sustainable payout ratio.
  • 1CVS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP722.81%
EPS Next 2Y15.59%
EPS Next 3Y15.31%
1CVS.MI Yearly Income VS Free CF VS Dividend1CVS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B
1CVS.MI Dividend Payout.1CVS.MI Dividend Payout, showing the Payout Ratio.1CVS.MI Dividend Payout.PayoutRetained Earnings

CVS HEALTH CORP

BIT:1CVS (2/12/2026, 7:00:00 PM)

66.41

+4.15 (+6.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-10
Earnings (Next)04-29
Inst Owners89.6%
Inst Owner ChangeN/A
Ins Owners0.99%
Ins Owner ChangeN/A
Market Cap84.30B
Revenue(TTM)394.08B
Net Income(TTM)469.00M
Analysts80
Price Target79.91 (20.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.44%
Yearly Dividend2.28
Dividend Growth(5Y)5.96%
DP722.81%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.34%
Min EPS beat(2)15.69%
Max EPS beat(2)22.99%
EPS beat(4)4
Avg EPS beat(4)24.17%
Min EPS beat(4)15.69%
Max EPS beat(4)30.76%
EPS beat(8)6
Avg EPS beat(8)6.87%
EPS beat(12)10
Avg EPS beat(12)5.67%
EPS beat(16)14
Avg EPS beat(16)5.3%
Revenue beat(2)2
Avg Revenue beat(2)3.34%
Min Revenue beat(2)3.04%
Max Revenue beat(2)3.64%
Revenue beat(4)3
Avg Revenue beat(4)1.56%
Min Revenue beat(4)-0.46%
Max Revenue beat(4)3.64%
Revenue beat(8)5
Avg Revenue beat(8)0.97%
Revenue beat(12)9
Avg Revenue beat(12)1.97%
Revenue beat(16)13
Avg Revenue beat(16)2.12%
PT rev (1m)3.29%
PT rev (3m)14.72%
EPS NQ rev (1m)0.46%
EPS NQ rev (3m)4.72%
EPS NY rev (1m)0.85%
EPS NY rev (3m)4.49%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)2.24%
Revenue NY rev (1m)0.3%
Revenue NY rev (3m)1.34%
Valuation
Industry RankSector Rank
PE 11.39
Fwd PE 10.78
P/S 0.25
P/FCF 15.74
P/OCF 10.88
P/B 1.36
P/tB N/A
EV/EBITDA N/A
EPS(TTM)5.83
EY8.78%
EPS(NY)6.16
Fwd EY9.28%
FCF(TTM)4.22
FCFY6.35%
OCF(TTM)6.11
OCFY9.19%
SpS264.14
BVpS48.88
TBVpS-25.83
PEG (NY)0.47
PEG (5Y)N/A
Graham Number80.07
Profitability
Industry RankSector Rank
ROA 0.18%
ROE 0.64%
ROCE 6.61%
ROIC 4.9%
ROICexc 5.26%
ROICexgc 19.51%
OM 2.73%
PM (TTM) 0.12%
GM 13.88%
FCFM 1.6%
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
ROICexc(3y)6.76%
ROICexc(5y)6.87%
ROICexgc(3y)25.87%
ROICexgc(5y)25.07%
ROCE(3y)8.35%
ROCE(5y)8.51%
ROICexgc growth 3Y-10.65%
ROICexgc growth 5Y-1.15%
ROICexc growth 3Y-14.28%
ROICexc growth 5Y-4.08%
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-4.91%
F-Score6
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 10.46
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.71%
Interest Coverage -3.53
Cash Conversion N/A
Profit Quality 1341.79%
Current Ratio 0.83
Quick Ratio 0.63
Altman-Z 2.26
F-Score6
WACC7.68%
ROIC/WACC0.64
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.81%
Cap/Sales(5y)0.84%
Profit Quality(3y)191.23%
Profit Quality(5y)191.5%
High Growth Momentum
Growth
EPS 1Y (TTM)7.87%
EPS 3Y-13.62%
EPS 5Y-5.2%
EPS Q2Q%46.79%
EPS Next Y24.02%
EPS Next 2Y15.59%
EPS Next 3Y15.31%
EPS Next 5Y13.81%
Revenue 1Y (TTM)6.82%
Revenue growth 3Y8.47%
Revenue growth 5Y7.74%
Sales Q2Q%7.8%
Revenue Next Year7.59%
Revenue Next 2Y5.06%
Revenue Next 3Y5.17%
Revenue Next 5Y4.65%
EBIT growth 1Y-3.81%
EBIT growth 3Y-12.98%
EBIT growth 5Y-4.24%
EBIT Next Year46.78%
EBIT Next 3Y19.74%
EBIT Next 5Y17.54%
FCF growth 1Y-44.32%
FCF growth 3Y-26.21%
FCF growth 5Y-9.45%
OCF growth 1Y-35.44%
OCF growth 3Y-20.7%
OCF growth 5Y-6.65%

CVS HEALTH CORP / 1CVS.MI FAQ

What is the fundamental rating for 1CVS stock?

ChartMill assigns a fundamental rating of 4 / 10 to 1CVS.MI.


What is the valuation status of CVS HEALTH CORP (1CVS.MI) stock?

ChartMill assigns a valuation rating of 6 / 10 to CVS HEALTH CORP (1CVS.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for CVS HEALTH CORP?

CVS HEALTH CORP (1CVS.MI) has a profitability rating of 3 / 10.


How financially healthy is CVS HEALTH CORP?

The financial health rating of CVS HEALTH CORP (1CVS.MI) is 3 / 10.


Is the dividend of CVS HEALTH CORP sustainable?

The dividend rating of CVS HEALTH CORP (1CVS.MI) is 6 / 10 and the dividend payout ratio is 722.81%.